This study investigated the antibacterial activity of propolis produced by A. mellifera and Brazilian stingless bees, called "meliponíneos". Susceptibility tests to ethanolic extracts of propolis (EEP) were performed using bacterial strains (Staphylococcus aureus, Enterococcus sp, and Escherichia coli) isolated from human infections. Dilution of EEP in agar (%v/v) was used for determination of minimal inhibitory concentration (MIC). The stingless bee species (and common names) were: Nannotrigona testaceicornis ("Iraí"), Tetragonisca angustula ("Jataí"), Trigona spinipes ("Arapuá"), Scaptotrigona sp ("Tiúba"), Partamona sp ("Cupira"), Melipona scutellaris ("Uruçu"), Melipona sp ("Manduri"), and Melipona mandaçaia ("Mandaçaia"). EEP inhibitory efficiencies according to bacterial strains were: S. aureus - "Cupira" > "Manduri" = A. mellifera > "Uruçu" > "Mandaçaia" > "Iraí" > "Tiúba" > "Jataí" > "Arapuá" = Ethanol; Enterococcus sp - "Cupira" > "Manduri" > A. mellifera > "Mandaçaia" > "Uruçu" > "Tiúba" > "Jataí" > "Arapuá" = Ethanol; E. coli - "Manduri" > "Jataí" > Ethanol > A. mellifera > "Uruçu" > "Cupira" > "Iraí". Propolis produced by "Cupira" and "Manduri" bees showed higher antibacterial activity than A. mellifera.
No takes yet. Share an insight, caveat, or question.
Fernandes et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: